AURA

Aura BiosciencesD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

AURA vs peer average

37/100

AURA vs. peer average (D vs. C)

Grade spread

A 1 · B 1 · C 4 · D 5

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

XFOR is the first available peer comparator.

X4 Pharmaceuticals is a small-cap clinical biotech where valuation is also heavily tied to milestone timing, readout credibility, and financing durability, though the disease focus differs.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerXFORX4

AURA

Aura Biosciences

XFOR

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs XFOR

AURA / XFOR

Grade Position

Below peers

AURA vs. peer average (D vs. C)

37/100

Momentum

AURA

Value

AURA

Sentiment

XFOR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs AURA

XFOR

40/100

Even

RLMD

60/100

-1

PALI

80/100

-2

CLYM

Climb Bio Inc Common

40/100

Even

IMMX

Immix Biopharma Inc Common

60/100

-1

XFOR is the first peer returned for this comparison set.